Disease Management Apps Market To Reach $22.44 Billion By 2030

Disease Management Apps Market Growth & Trends

The global disease management apps market size is expected to reach USD 22.44 billion by 2030, expanding at a CAGR of 12.1% from 2024 to 2030, according to a new study by Grand View Research, Inc. The rising consumer demand to monitor their health and growing trends of prioritizing healthy lifestyles are anticipated to drive the global market. Moreover, increasing smartphone and internet penetration and surging trend of preventive healthcare are also expected to propel the market to a certain extent.

The rising consumer awareness about health risks associated with poor nutrition is bolstering the demand for disease management apps. Some of the common disease management apps are Medisafe, Sleep Cycle and others. According to the Tech Report published in May 2024, approximately 1.36 billion people worldwide, which represents over 18.55% of the global population, own an iPhone. Additionally, a significant portion of smartphone users, estimated to be around 52%, utilize their devices to obtain health-related information.

In addition, the emergence of novel technologies and flourishing demand for disease management apps with other parameters has driven the market at a rapid pace. Moreover, increasing initiatives by market participants to develop enhanced applications owing to their escalated demand is further fueling market uptake. For instance, in June 2023, the Centers for Medicare & Medicaid Services (CMS) unveiled the Making Care Primary (MCP) Model, a new voluntary primary care model. The initiative is scheduled to launch in 2024 and is designed to last for 10.5 years, with the goal of improving care management and coordination in primary care settings.

 Request a free sample copy or view report summary: Disease Management Apps Market Report

Disease Management Apps Market Report Highlights

• Based on platform, theAndroid segment accounted for the largest revenue share in 2023 and is anticipated to grow at the fastest CAGR of 12.7% during the forecast period. The growth is attributed to the rising numbers of Android users, and rising penetration of telemedicine specially in developing countries including China and India

• Based on device, the smartphones segment accounted for the largest market share in 2023. The growth is attributed to the constant product developments in terms of features and functions, rising inclination for fitness tracking, health monitoring, and increasing demand for advanced products

• Based on indication, the mental health segment accounted for the largest revenue share in 2023 owing to the rising concerns about mental health, significant demand for effective and efficient mental health management systems

• In 2023, North America dominated the overall market owing to rising awareness among people to adopt mhealth and digital health applications, high internet, and smartphones penetration

Disease Management Apps Market Segmentation

Grand View Research has segmented the global disease management apps market based on platform, device, indication, and region:

Disease Management Apps Platform Outlook (Revenue, USD Million, 2018 - 2030)

• iOS

• Android

• Others

Disease Management Apps Device Outlook (Revenue, USD Million, 2018 - 2030)

• Smartphones

• Tablets

• Wearables

Disease Management Apps Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Obesity

• Cardiovascular Issues

• Mental Health

• Diabetes

• Others

Disease Management Apps Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Norway

  • Sweden

  • Denmark

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Disease Management Apps Market

• Fitbit LLC.

• Healthy.io.Ltd

• MyFitnessPal, Inc.

• Noom, Inc.

• Azumio Inc.

• Medisafe

• Sleep Cycle

• Curable, Inc

• Bearable Ltd

• Omada Health Inc.